Metrics as of 10/13/2026, 06:35 PM (Berlin time), refresh in progress.
PureTech Health Stock
PureTech Health plc
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Robert William Henry Lyne
- Employees
- 56
- Market cap
- $4.2 B
- IPO
- 16/11/2020
PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments:…
PureTech Health stock: price history
1D
+2.0%
1W
-0.5%
1M
-5.1%
6M
+10.1%
YTD
+4.7%
1Y
-0.0%
2Y
-39.3%
5Y
-66.9%
10Y
–
Next earnings date
Next earnings date
No date known
Volatility around earnings
~17% weaker price swings than usual
Ask the agents about PureTech Health
Analyst assessment of PureTech Health
PRICE TARGET LOW
US$44.00
CONSENSUS
US$57.00
MEDIAN
US$57.00
PRICE TARGET HIGH
US$70.00
0
STRONG BUY
2
BUY
0
HOLD
0
SELL
0
STRONG SELL
2
TOTAL · Buy
As of: 25/08/2022
PureTech Health stock metrics
P/E
-0.6
P/B
0.13
EV/EBITDA
-42.08
RETURN ON EQUITY
-20.8%
NET MARGIN
-2,319.6%
DEBT/EQUITY
0.06
DIVIDEND YIELD
0.0%
AS OF
31/12/2025
Free float & liquidity
FREE FLOAT
64.6%
FLOAT SHARES
15,717,999
AVG. DAILY VOLUME (30D)
13,705
Institutional holders
Comparable stocks
Frequently asked questions about PureTech Health stock
What does PureTech Health do?
PureTech Health plc is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Robert William Henry Lyne, the company employs around 56 people.
The IPO was on 16/11/2020; the stock trades on NASDAQ under the ticker PRTC.
What do analysts say about PureTech Health stock?
2 analysts rate the stock, the consensus is Buy (as of 25/08/2022).
The average price target is US$57.00, ranging from US$44.00 to US$70.00, with a median of US$57.00.
This is an external assessment, not a statement by Market Jury.
When does PureTech Health report next?
Around past earnings, price swings were roughly -17% stronger than usual.
Does PureTech Health pay a dividend?
No, PureTech Health currently does not pay a dividend.
Which stocks are comparable to PureTech Health?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get PureTech Health stock analyzed?
Clicking "Analyze stock" lets five strategies assess PureTech Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.